Physician profile
Ragitha Subodh
NPI 1336594142
$5,810.76
in general payments reported to CMS, 2019-2025
11 companies · $436 in 2025
The $436 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.85 · 2022: $2,563 · 2023: $728 · 2024: $2,057 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,469 · Travel and Lodging: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,468.65 |
| Travel and Lodging | $751.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,039.55 | 2021-2022 | |
| Boston Scientific Corporation | $1,993.83 | 2022-2025 | Watchman Flx |
| Edwards Lifesciences Corporation | $984.83 | 2022-2023 | Sapien 3 Ultra Resilia, Pascal |
| E.R. Squibb & Sons, L.L.C. | $197.06 | 2023-2025 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $186.36 | 2022-2023 | Lifevest |
| Pfizer INC. | $120.36 | 2024-2025 | |
| W. L. Gore & Associates, INC. | $103.56 | 2023-2025 | Gore Cardioform Septal Occluder, Gore Cardioform Asd Occluder |
| Astrazeneca Pharmaceuticals LP | $87.91 | 2023-2025 | Wainua, Farxiga |
| Alnylam Pharmaceuticals INC. | $56.55 | 2024 | Onpattro |
| Abbott Laboratories | $21.60 | 2024 | Epic |
| Lantheus Medical Imaging, INC. | $19.15 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ragitha Subodh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.